Biogen Inc. buy Royal Bank of Canada
Start price
13.02.25
/
50%
€130.50
Target price
13.02.26
€215.73
Performance (%)
26.32%
End price
14.02.26
€164.85
Summary
This prediction ended on 14.02.26 with a price of €164.85. The prediction had a final performance of 26.32%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 2.181% | 2.181% | 64.049% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $231.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten